Preclinical Studies of Neural Stem/Progenitor Cell Therapy for Ischemic Stroke: A Systematic Review

CONCLUSION: Most of the preclinical studies reported statistically significant effects and very few adverse reactions. Transplantation of NSPCs for ischemic stroke still needs to be optimized for several key factors. A standardized treatment outcome assessment could ease the translation of evidence in clinical settings.PMID:35410620 | DOI:10.2174/1574888X17666220410221905

Source: Cell Research - April 12, 2022 Category: Cytology Authors: Mengze Zhang Kan Wang Chunran Xue Chong Xie Ze Wang Yaying Song Haojun Yu Yong Hao Yangtai Guan Source Type: research